Terry L. Lierman - 13 Mar 2024 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
Director
Signature
/s/ Terry L. Lierman
Issuer symbol
IGC
Transactions as of
13 Mar 2024
Net transactions value
$0
Form type
4
Filing time
15 Mar 2024, 17:34:44 UTC
Previous filing
12 Mar 2024
Next filing
21 Oct 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC OPTIONS Award $0 +150,000 $0.000000 150,000 13 Mar 2024 Common Stock 150,000 $0.3000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 150,000 options to buy shares of common stock, 50,000 vesting immediately and 100,000 subject to vesting over two years in equal parts starting 2025, as per the IGC Board of Directors Agreement with Mr. Lierman.
F2 Exercisable in equal amounts on March 2024, 2025 & 2026.